These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18299330)

  • 1. Human cytidine deaminase APOBEC3H restricts HIV-1 replication.
    Dang Y; Siew LM; Wang X; Han Y; Lampen R; Zheng YH
    J Biol Chem; 2008 Apr; 283(17):11606-14. PubMed ID: 18299330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
    Binka M; Ooms M; Steward M; Simon V
    J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.
    Mitra M; Singer D; Mano Y; Hritz J; Nam G; Gorelick RJ; Byeon IJ; Gronenborn AM; Iwatani Y; Levin JG
    Retrovirology; 2015 Jan; 12():3. PubMed ID: 25614027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.
    Chaipan C; Smith JL; Hu WS; Pathak VK
    J Virol; 2013 Jan; 87(1):444-53. PubMed ID: 23097438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Structural Interface between HIV-1 Vif and Human APOBEC3H.
    Ooms M; Letko M; Simon V
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.
    Zhen A; Wang T; Zhao K; Xiong Y; Yu XF
    J Virol; 2010 Feb; 84(4):1902-11. PubMed ID: 19939923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.
    Bohn JA; DaSilva J; Kharytonchyk S; Mercedes M; Vosters J; Telesnitsky A; Hatziioannou T; Smith JL
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3 proteins can copackage and comutate HIV-1 genomes.
    Desimmie BA; Burdick RC; Izumi T; Doi H; Shao W; Alvord WG; Sato K; Koyanagi Y; Jones S; Wilson E; Hill S; Maldarelli F; Hu WS; Pathak VK
    Nucleic Acids Res; 2016 Sep; 44(16):7848-65. PubMed ID: 27439715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
    Zhang W; Chen G; Niewiadomska AM; Xu R; Yu XF
    PLoS One; 2008; 3(12):e3963. PubMed ID: 19088851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
    Ooms M; Krikoni A; Kress AK; Simon V; Münk C
    J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.
    Ooms M; Letko M; Binka M; Simon V
    PLoS One; 2013; 8(2):e57744. PubMed ID: 23469063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.
    Smith JL; Izumi T; Borbet TC; Hagedorn AN; Pathak VK
    J Virol; 2014 Sep; 88(17):9893-908. PubMed ID: 24942576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation.
    Nakano Y; Misawa N; Juarez-Fernandez G; Moriwaki M; Nakaoka S; Funo T; Yamada E; Soper A; Yoshikawa R; Ebrahimi D; Tachiki Y; Iwami S; Harris RS; Koyanagi Y; Sato K
    PLoS Pathog; 2017 May; 13(5):e1006348. PubMed ID: 28475648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
    Marin M; Golem S; Rose KM; Kozak SL; Kabat D
    J Virol; 2008 Jan; 82(2):987-98. PubMed ID: 17977970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif.
    Nakashima M; Tsuzuki S; Awazu H; Hamano A; Okada A; Ode H; Maejima M; Hachiya A; Yokomaku Y; Watanabe N; Akari H; Iwatani Y
    J Mol Biol; 2017 Apr; 429(8):1262-1276. PubMed ID: 28336404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.
    Tan L; Sarkis PT; Wang T; Tian C; Yu XF
    FASEB J; 2009 Jan; 23(1):279-87. PubMed ID: 18827027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
    Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
    Han Y; Wang X; Dang Y; Zheng YH
    PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.